XUNFEIHEALTH (02506) Wins Top Prize in National Smart Healthcare Competition, Business Model Supports High Growth

Stock News
2025/12/09

XUNFEIHEALTH (02506), in collaboration with the Anhui Medical Insurance Bureau and other institutions, secured first prize in the 2025 National Smart Healthcare Competition Finals with its project, *"Leading the Future – Data Value Chain and Industry Ecosystem Empowerment Based on the Medical Insurance Imaging Cloud Platform."* This national-level recognition highlights the company’s strong capabilities in smart healthcare solutions.

China’s healthcare system has long grappled with challenges such as the difficulty in mutual recognition of medical test results. Leveraging its Spark Medical AI model, XUNFEIHEALTH contributed to the development of Anhui’s Medical Insurance Imaging Cloud Platform, which provides a systematic solution. Operating under a *"government-led, market-operated"* model, the platform has connected over 1,900 medical institutions across the province, securely storing more than 140 million medical imaging records and facilitating over 10.8 million remote diagnoses. It has saved approximately 2 billion yuan annually in medical insurance costs and became the first regional imaging cloud platform integrated with the National Medical Insurance System.

The platform continues to innovate in AI-driven medical imaging diagnostics. Moving beyond single-disease AI applications, it has developed a comprehensive multimodal medical imaging model capable of automatic multi-disease identification and quality control. Additionally, it accelerates technology commercialization by collaborating with research teams nationwide to enhance the platform’s intelligence, precision, and accessibility.

This competition victory not only underscores XUNFEIHEALTH’s technological prowess but also accelerates the replication and expansion of its business model. With China’s *"AI + Healthcare"* policy gaining momentum, the company—backed by its deep expertise in medical insurance, hospital systems, and primary healthcare—is well-positioned to expand its market presence. Bolstered by its Hong Kong IPO, which broadens financing channels, XUNFEIHEALTH is poised to solidify its leadership and achieve high-quality growth in the smart healthcare sector.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10